Clinical Trial Update: IV Double and Triple Concentrated Nicardipine for Stroke and ICH [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating intravenous nicardipine in double/triple concentrated formulations for stroke and intracerebral hemorrhage; status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• Nicardipine (nicardipine)

Snippet

Sponsor: OSF Healthcare System | Conditions: Hypertension | Phase 4 | Status: UNKNOWN